Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1979 Jun;38(3):244–247. doi: 10.1136/ard.38.3.244

Thrombokinetics in giant cell arteritis, with special reference to corticosteroid therapy.

A L Bergström, B A Bengtsson, L B Olsson, B E Malmvall, J Kutti
PMCID: PMC1000445  PMID: 485582

Abstract

Duplicate platelet survival studies were carried out on 8 patients with giant cell arteritis (GCA), once before the institution of any therapy, and the second time when they were in a completely asymptomatic phase after having received corticosteroid treatment. The time interval between the studies ranged between 5 and 14 months. In the first study the mean peripheral platelet count was 486 +/- 25 X 10(9)/l and in the second 326 +/- 25 X 10(9)/l. The difference between the means was highly significant (P less than 0.001). The mean life-span of the platelets was normal in the duplicate experiments (6.7 +/- 0.3 and 7.3 +/- 0.4 days, respectively). Platelet production rate was significantly (P less than 0.001) raised in the first experiment but became normal in response to corticosteroid therapy. It is concluded that the thrombocytosis seen in GCA is reactive to the inflammation present in this disease, and it seems reasonable to assume that the reduction in the peripheral platelet count which occurs in response to corticosteroid therapy accurately reflects the clinical improvement of the patient.

Full text

PDF
244

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTER R. H., JANDL J. H. PLATELET SEQUESTRATION IN MAN. I. METHODS. J Clin Invest. 1964 May;43:843–855. doi: 10.1172/JCI104970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BRECHER G., SCHNEIDERMAN M., CRONKITE E. P. The reproducibility and constancy of the platelet count. Am J Clin Pathol. 1953 Jan;23(1):15–26. doi: 10.1093/ajcp/23.1.15. [DOI] [PubMed] [Google Scholar]
  3. DORNHORST A. C. The interpretation of red cell survival curves. Blood. 1951 Dec;6(12):1284–1292. [PubMed] [Google Scholar]
  4. Harker L. A., Finch C. A. Thrombokinetics in man. J Clin Invest. 1969 Jun;48(6):963–974. doi: 10.1172/JCI106077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Irving J. T. The effect of dietary restriction upon the incisor teeth of rachitic rats. J Physiol. 1946 Jul 15;105(1):16–23. [PMC free article] [PubMed] [Google Scholar]
  6. Kutti J., Ridell B., Weinfeld A., Westin J. The relation of thrombokinetics to bone marrow megakaryocytes and to the size of the spleen in polycythaemia vera. Scand J Haematol. 1973;10(2):88–95. doi: 10.1111/j.1600-0609.1973.tb00045.x. [DOI] [PubMed] [Google Scholar]
  7. Kutti J., Safai-Kutti S. In vitro labelling of platelets: an experimental study on healthy asplenic subjects using two different incubation media. Br J Haematol. 1975 Sep;31(1):57–64. doi: 10.1111/j.1365-2141.1975.tb00832.x. [DOI] [PubMed] [Google Scholar]
  8. Kutti J., Weinfeld A. Platelet survival in man. Scand J Haematol. 1971;8(5):336–346. doi: 10.1111/j.1600-0609.1971.tb00883.x. [DOI] [PubMed] [Google Scholar]
  9. OLHAGEN B. POLYMYALGIA RHEUMATICA. A FORM OF SENILE ARTERITIS? Acta Rheumatol Scand. 1963;9:157–164. [PubMed] [Google Scholar]
  10. Weinfeld A., Branehög I., Kutti J. Platelets in the myeloproliferative syndrome. Clin Haematol. 1975 Jun;4(2):373–392. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES